Homo sapiens vascular endothelial junction-associated molecule mRNA, c - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma. [J Gene Med. 2024]
JAM2 is a prognostic biomarker and inhibits proliferation, metastasis and epithelial-mesenchymal transition in lung adenocarcinoma.
Dong Y, Zhang J, Xie S, Di S, Fan B, Gong T. J Gene Med. 2024 Feb; 26(2):e3679.
JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer. [Int Immunopharmacol. 2022]
JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer.
Peng Y, Li H, Fu Y, Guo S, Qu C, Zhang Y, Zong B, Liu S. Int Immunopharmacol. 2022 Feb; 103:108430. Epub 2021 Dec 17.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. [Cell. 2021]
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Huttlin EL, Bruckner RJ, Navarrete-Perea J, Cannon JR, Baltier K, Gebreab F, Gygi MP, Thornock A, Zarraga G, Tam S, et al. Cell. 2021 May 27; 184(11):3022-3040.e28. Epub 2021 May 6.

RefSeq alternative splicing
See 3 reference mRNA sequence splice variants for the JAM2 gene.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide